StockDriftsStockDriftsTea Vaccine Research Institute (261780) has 1 disclosed insider purchases and 1 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩75M ($52K) in reported transaction value. The earliest filing StockDrifts holds for Tea Vaccine Research Institute is dated 2024-03-29; the most recent is 2026-04-30. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +9.49%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | SELL | 장외매도 | 차바이오텍 CHA Biotech | - | -8.9M | ₩4,100 | -8.9% | ₩36.7B ($25.5M) |
| 2026-03-26 | SELL | Market Sell | 고정재 fixing material | Internal director | -14.3K | ₩4,530 | +22.1% | ₩65M ($45K) |
| 2025-09-25 | BUY | Market Buy | HAN SEUNGIL | CEO | 3.7K | ₩2,735 | -3.1% | ₩10M ($7K) |
| 2025-04-01 | BUY | 주식매수선택권 | 고정재 fixing material | Internal director | 26.7K | ₩2,830 | -6.4% | ₩75M ($52K) |
| 2024-03-29 | BUY | 주식매수선택권 | 조정기 regulator | president | 50.0K | ₩5,140 | -48.4% | ₩257M ($178K) |
| 2024-03-29 | BUY | 주식매수선택권 | 고정재 fixing material | Internal director | 26.7K | ₩5,140 | -48.4% | ₩137M ($95K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Tea Vaccine Research Institute. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.